SEC Filing Details

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.

SEC Filing Details

Document Details

Form
Filing Date
Jan 4, 2019
Document Date
Jan 4, 2019
Form Description
Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Poseida Therapeutics, Inc.
Issuer
Poseida Therapeutics, Inc.